Literature DB >> 2185995

Detection of antibodies to human T-lymphotropic virus type I by using synthetic peptides.

N Kuroda1, Y Washitani, H Shiraki, H Kiyokawa, M Ohno, H Sato, Y Maeda.   

Abstract

We describe an enzyme-linked immunosorbent assay (ELISA) for antibodies to HTLV-I using synthetic peptides corresponding to antigenic regions of HTLV-I structural protein. We observed that the peptides amino acid 100-119, 100-130, 131-160 and 295-314 of the gag protein, and 89-115, 175-199, 350-386 and 458-488 on the env protein correspond to the antigenic regions of HTLV-I structural protein. In particular, the peptide corresponding to amino acid 100-130 of the gag protein reacted with antibodies in all sera from HTLV-I carriers diagnosed by particle agglutination assay (PA) and indirect immunofluorescence assay (IF), but did not react with sera from healthy volunteers judged to be negative by PA and IF. Our results indicate that the ELISA using the peptide 100-130 of the gag protein can be used for donor screening of HTLV-I antibodies.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2185995     DOI: 10.1002/ijc.2910450514

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

1.  Characterization of immunodominant epitopes of gag and pol gene-encoded proteins of human T-cell lymphotropic virus type I.

Authors:  R B Lal; D L Rudolph; K P Griffis; K Kitamura; M Honda; J E Coligan; T M Folks
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

2.  Trypsin-sensitive and -resistant components in human T-cell membranes required for syncytium formation by human T-cell lymphotropic virus type 1-bearing cells.

Authors:  Y Sagara; C Ishida; Y Inoue; H Shiraki; Y Maeda
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

3.  Identification of the region including the epitope for a monoclonal antibody which can neutralize human parvovirus B19.

Authors:  H Sato; J Hirata; M Furukawa; N Kuroda; H Shiraki; Y Maeda; K Okochi
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

4.  71-kilodalton heat shock cognate protein acts as a cellular receptor for syncytium formation induced by human T-cell lymphotropic virus type 1.

Authors:  Y Sagara; C Ishida; Y Inoue; H Shiraki; Y Maeda
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

5.  Identification of functional regions in the human T-cell leukemia virus type I SU glycoprotein.

Authors:  L Delamarre; C Pique; D Pham; T Tursz; M C Dokhélar
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

6.  Synthetic peptide-based immunoassays for distinguishing between human T-cell lymphotropic virus type I and type II infections in seropositive individuals.

Authors:  R B Lal; W Heneine; D L Rudolph; W B Present; D Hofhienz; T M Hartley; R F Khabbaz; J E Kaplan
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

7.  Identification and mapping of functional domains on human T-cell lymphotropic virus type 1 envelope proteins by using synthetic peptides.

Authors:  Y Sagara; Y Inoue; H Shiraki; A Jinno; H Hoshino; Y Maeda
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

8.  Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens.

Authors:  Y Washitani; N Kuroda; H Shiraki; Y Itoyama; H Sato; K Ohshima; H Kiyokawa; Y Maeda
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

9.  Discrimination between human T-cell lymphotropic virus type I and II (HTLV-I and HTLV-II) infections by using synthetic peptides representing an immunodominant region of the core protein (p19) of HTLV-I and HTLV-II.

Authors:  J Bonis; A Baillou; F Barin; M Verdier; B Janvier; F Denis
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.